$ONFO
Onfolio Holdings, Inc Stock $onfo

$onfo Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000165495423004611 Filed on April 12, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.352M	$1.124M	$2.220M
YoY Change	250.26%	158.98%	22.74%
Cost Of Revenue	$608.5K	$371.6K	$1.021M
YoY Change	170.73%	-41.87%	-4.86%
Gross Profit	$743.2K	$752.1K	$1.198M
YoY Change	361.19%	-466.14%	63.05%
Gross Profit Margin	54.98%	66.93%	53.99%
Selling, General & Admin	$1.696M	$1.380M	$4.272M
YoY Change	84.77%	137.23%	58.96%
% of Gross Profit	228.25%	183.42%	356.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$171.0K	$124.8K	$124.8K
YoY Change
% of Gross Profit	23.01%	16.6%	10.42%
Operating Expenses	$2.094M	$1.380M	$5.310M
YoY Change	128.13%	137.23%	97.58%
Operating Profit	-$1.351M	-$627.4K	-$4.111M
YoY Change	78.51%	-20.27%	110.58%
Interest Expense	$64.29K	$11.12K	$35.48K
YoY Change	687.87%	-48.04%	-30.21%
% of Operating Profit
Other Income/Expense, Net	$67.09K	$30.34K	-$123.2K
YoY Change	721.79%		-342.31%
Pretax Income	-$1.284M	-$1.251M	-$4.234M
YoY Change	71.49%	63.46%	122.69%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.284M	-$1.309M	-$4.234M
YoY Change	71.49%	71.31%	122.84%
Net Earnings / Revenue	-94.99%	-116.5%	-190.75%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.26	-$0.26	-$1.35
COMMON SHARES
Basic Shares Outstanding	5.110M shares	5.110M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.664M	$6.701M	$6.701M
YoY Change	278.98%	291.81%	291.81%
Cash & Equivalents	$4.664M	$6.701M
Short-Term Investments
Other Short-Term Assets	$241.5K	$212.2K	$212.2K
YoY Change	35.23%	32.79%	32.79%
Inventory	$90.30K	$105.1K	$105.1K
Prepaid Expenses
Receivables	$115.0K	$137.6K	$137.6K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.110M	$7.156M	$7.156M
YoY Change	232.79%	260.85%	260.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$4.220M	$4.209M
YoY Change
Intangibles	$4.556M	$3.865M
YoY Change		178.38%
Long-Term Investments	$278.8K	$434.3K	$434.3K
YoY Change	-37.06%	3.96%	3.96%
Other Assets	$127.8K	$111.7K	$111.7K
YoY Change	-5.39%	118.63%	118.63%
Total Long-Term Assets	$9.336M	$8.620M	$8.620M
YoY Change	374.78%	364.14%	364.14%
TOTAL ASSETS
Total Short-Term Assets	$5.110M	$7.156M	$7.156M
Total Long-Term Assets	$9.336M	$8.620M	$8.620M
Total Assets	$14.45M	$15.78M	$15.78M
YoY Change	312.52%	310.8%	310.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$342.7K	$550.5K	$550.5K
YoY Change	30.89%	147.35%	147.35%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$48.63K	$68.96K	$68.96K
YoY Change	630.18%	141.88%	141.88%
Long-Term Debt Due	$2.416M	$2.456M	$2.456M
YoY Change	13851.04%	14081.99%	14081.99%
Total Short-Term Liabilities	$3.083M	$3.303M	$3.303M
YoY Change	440.53%	960.61%	960.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.083M	$3.303M	$3.303M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.083M	$3.303M	$3.303M
YoY Change	440.53%	608.18%	608.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.916M	-$7.580M
YoY Change		140.58%
Common Stock	$418.2K	$418.2K
YoY Change		3631.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.36M	$12.47M	$12.47M
YoY Change
Total Liabilities & Shareholders Equity	$14.45M	$15.78M	$15.78M
YoY Change	312.52%	310.8%	310.8%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.284M	-$1.309M	-$4.234M
YoY Change	71.49%	71.31%	122.84%
Depreciation, Depletion And Amortization	$171.0K	$124.8K	$124.8K
YoY Change
Cash From Operating Activities	-$1.022M	-$497.3K	-$2.871M
YoY Change	88.4%	-26.93%	151.73%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions	$850.0K		$4.261M
YoY Change
Other Investing Activities	-$850.0K	-$4.306M	-$4.283M
YoY Change	3677.78%	-692.01%	-26753.52%
Cash From Investing Activities	-$850.0K	-$4.306M	-$4.283M
YoY Change	3677.78%	7511.19%	457.76%
FINANCING ACTIVITIES
Cash Dividend Paid	$74.99K		$142.2K
YoY Change	2426.75%		35.05%
Common Stock Issuance & Retirement, Net			$12.10M
YoY Change			253.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$135.3K	-146.1K	$12.11M
YoY Change	-258.87%	-107.36%	291.0%
NET CHANGE
Cash From Operating Activities	-$1.022M	-497.3K	-$2.871M
Cash From Investing Activities	-$850.0K	-4.306M	-$4.283M
Cash From Financing Activities	-$135.3K	-146.1K	$12.11M
Net Change In Cash	-$2.038M	-4.950M	$4.991M
YoY Change	324.69%	-497.0%	319.89%
FREE CASH FLOW
Cash From Operating Activities	-$1.022M	-$497.3K	-$2.871M
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$497.3K	-$2.871M
YoY Change		-580.88%	705.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001825452
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110195	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2353645	shares
CY2021	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2022	onfolio	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised	0
CY2021	onfolio	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised	0
CY2021	onfolio	Weighted Average Grant Date Fair Value Forfeited And Cancelled WeightedAverageGrantDateFairValueForfeitedAndCancelled	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	56600	shares
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P8M30D
CY2022	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0123	pure
CY2022	us-gaap	Policyholder Dividends Rate On Policy Earnings PolicyholderDividendsRateOnPolicyEarnings	0	pure
CY2022	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	49560	shares
CY2022	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	363000	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41466
CY2022	dei	Entity Registrant Name EntityRegistrantName	Onfolio Holdings Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1978697
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1007 North Orange Street, 4th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
CY2022	dei	City Area Code CityAreaCode	682
CY2022	dei	Local Phone Number LocalPhoneNumber	990-6920
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022	dei	Trading Symbol TradingSymbol	ONFO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	2095412	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5110195	shares
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6701122	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1710318	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	137598	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	14624	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	105129	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98397	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	212180	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	159791	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7156029	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1983130	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3864618	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1388260	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4209126	usd
CY2021Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	111720	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	51095	usd
CY2022Q4	onfolio	Investment In Unconsolidated Joint Ventures Cost Method InvestmentInUnconsolidatedJointVenturesCostMethod	154007	usd
CY2021Q4	onfolio	Investment In Unconsolidated Joint Ventures Cost Method InvestmentInUnconsolidatedJointVenturesCostMethod	138401	usd
CY2022Q4	onfolio	Investment In Unconsolidated Joint Ventures Equity Method InvestmentInUnconsolidatedJointVenturesEquityMethod	280326	usd
CY2021Q4	onfolio	Investment In Unconsolidated Joint Ventures Equity Method InvestmentInUnconsolidatedJointVenturesEquityMethod	279382	usd
CY2022Q4	us-gaap	Assets Assets	15775826	usd
CY2021Q4	us-gaap	Assets Assets	3840268	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	550454	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	222543	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	54404	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1498	usd
CY2022Q4	onfolio	Due To Joint Ventures Current DueToJointVenturesCurrent	0	usd
CY2021Q4	onfolio	Due To Joint Ventures Current DueToJointVenturesCurrent	9105	usd
CY2022Q4	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	2456323	usd
CY2021Q4	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	17323	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	68959	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	28514	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	480	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	60000	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	113251	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	32000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3303391	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	311463	usd
CY2022Q4	onfolio	Due To Joint Ventures Long Term Non Current DueToJointVenturesLongTermNonCurrent	0	usd
CY2021Q4	onfolio	Due To Joint Ventures Long Term Non Current DueToJointVenturesLongTermNonCurrent	155000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3303391	usd
CY2021Q4	us-gaap	Liabilities Liabilities	466463	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110195	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2353645	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5110	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2354	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19950774	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6522382	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	96971	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7580490	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3150988	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12472435	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3373805	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15775826	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3840268	usd
CY2022	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	544822	usd
CY2021	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	507532	usd
CY2022	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	1674993	usd
CY2021	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	1301011	usd
CY2022	us-gaap	Revenues Revenues	2219815	usd
CY2021	us-gaap	Revenues Revenues	1808543	usd
CY2022	onfolio	Cost Of Revenue Services CostOfRevenueServices	356957	usd
CY2021	onfolio	Cost Of Revenue Services CostOfRevenueServices	447325	usd
CY2022	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	664405	usd
CY2021	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	626185	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1021362	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1073510	usd
CY2022	us-gaap	Gross Profit GrossProfit	1198453	usd
CY2021	us-gaap	Gross Profit GrossProfit	735033	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4271865	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2479152	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	509941	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	208193	usd
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	527792	usd
CY2021	us-gaap	Acquisition Costs AcquisitionCosts	0	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5309598	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2687345	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4111145	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1952312	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	34432	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	50684	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	3193	usd
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	9970	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2152	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9805	usd
CY2022	us-gaap	Other Income OtherIncome	13223	usd
CY2021	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	137602	usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-34306	usd
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-123212	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	50849	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4234357	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1901463	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1314	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4234357	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1900149	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4429502	usd
CY2022	onfolio	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-1.35
CY2021	onfolio	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.96
CY2022	onfolio	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	3285934	shares
CY2021	onfolio	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	2080733	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1187748	usd
CY2021	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	1415000	usd
CY2021	onfolio	Common Stock Sold For Cash Amount CommonStockSoldForCashAmount	2010000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	768030	usd
CY2021	onfolio	Preferred Dividends PreferredDividends	-106825	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1900148	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3373805	usd
CY2022	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	321500	usd
CY2022	onfolio	Common Stock Sold For Cash Amount CommonStockSoldForCashAmount	12104667	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	944995	usd
CY2022	onfolio	Warrants Issued For Acquisition WarrantsIssuedForAcquisition	60000	usd
CY2022	onfolio	Preferred Dividends PreferredDividends	-195145	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	96971	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4234357	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12472435	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4234357	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1900148	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1314	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	944995	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	768030	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	34432	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	50684	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	33488	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	63798	usd
CY2022	onfolio	Impairment Of Cost Method Investment ImpairmentOfCostMethodInvestment	51894	usd
CY2021	onfolio	Impairment Of Cost Method Investment ImpairmentOfCostMethodInvestment	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-34306	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	124832	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	122974	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39277	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8125	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58806	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	52389	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	142110	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	325706	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	185651	usd
CY2022	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-9730	usd
CY2021	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-7532	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	60123	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-480	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-39643	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2870893	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1140481	usd
CY2022	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	45694	usd
CY2021	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	75000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	784000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4261413	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	onfolio	Advances To Related Parties AdvancesToRelatedParties	0	usd
CY2021	onfolio	Advances To Related Parties AdvancesToRelatedParties	9526	usd
CY2022	onfolio	Investments In Joint Ventures InvestmentsInJointVentures	67500	usd
CY2021	onfolio	Investments In Joint Ventures InvestmentsInJointVentures	49401	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4283219	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-767927	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12104667	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2010000	usd
CY2022	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	321500	usd
CY2021	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	1415000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	142239	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	105327	usd
CY2022	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	215000	usd
CY2021	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	60000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	191170	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	44000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	108000	usd
CY2022	onfolio	Payments From Note Payables PaymentsFromNotePayables	3555	usd
CY2021	onfolio	Payments From Note Payables PaymentsFromNotePayables	79486	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12109373	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3097017	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35543	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4990804	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1188609	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1710318	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	521709	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6701122	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1710318	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7082	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	9805	usd
CY2022	onfolio	Notes Payable Issued For Asset Acquisitions NotesPayableIssuedForAssetAcquisitions	2439000	usd
CY2021	onfolio	Notes Payable Issued For Asset Acquisitions NotesPayableIssuedForAssetAcquisitions	0	usd
CY2022	onfolio	Other Other	0	usd
CY2021	onfolio	Other Other	1700	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	12860	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	56600	shares
CY2021	onfolio	Proceeds From Customers1 ProceedsFromCustomers1	1415000	usd
CY2021Q2	onfolio	Selling Intellectual Property SellingIntellectualProperty	75000	usd
CY2021	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	766656	usd
CY2022	us-gaap	Restricted Stock Award Forfeitures Dividends RestrictedStockAwardForfeituresDividends	2800	usd
CY2022Q4	onfolio	Accrued Cash Compensation AccruedCashCompensation	60000	usd
CY2022	us-gaap	Key Provisions Of Operating Or Partnership Agreement Description KeyProvisionsOfOperatingOrPartnershipAgreementDescription	During the year ended December 31, 2022, the Company issued a total of 49,560 options with an exercise price of $5.95, and an exercise term of three years. The Company estimated fair value of these options to be $4.41 per share using a Black-Scholes option pricing model, and the expense associated with the options will be recognized over the requite service period of 20 months
CY2022	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	23100	shares
CY2022	onfolio	Description Of Black Scholes Option Pricing Model DescriptionOfBlackScholesOptionPricingModel	1) dividend yield of 0%; 2) risk-free rate of 0.97% to 1.91%; 3) volatility of 127.7% to 129.5% based on a group of peer group companies; 4) a common stock price of $5.95 based on the most recent common stock sales for cash, and 5) an expected term of three years
CY2021	onfolio	Description Of Black Scholes Option Pricing Model DescriptionOfBlackScholesOptionPricingModel	the Company award 10,000 common stock options to an employee, of which 500 vested immediately, and 500 per month thereafter until fully vested. The fair value of the stock options was estimate using a black-Scholes option pricing model and the following assumptions: 1) dividend yield of 0%; 2) risk-free rate of 0.49%; 3) volatility of 127.6% based on a group of peer group companies
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2100	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	72660	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	14910	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.19
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59850	shares
CY2022Q4	onfolio	Weighted Average Grant Date Fair Valueending WeightedAverageGrantDateFairValueending	4.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.11
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	18189	shares
CY2022Q4	onfolio	Weighted Average Grant Date Fair Valueexercisable WeightedAverageGrantDateFairValueexercisable	4.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.40
CY2022Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	121672	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	138908	usd
CY2022Q4	onfolio	Due From Related Parties Included In Current Assets DueFromRelatedPartiesIncludedInCurrentAssets	54858	usd
CY2021Q4	onfolio	Paid To Related Party PaidToRelatedParty	215000	usd
CY2022Q4	onfolio	Due To Related Parties Included In Current Liabilities DueToRelatedPartiesIncludedInCurrentLiabilities	36854	usd
CY2021Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	54240	usd
CY2021Q1	us-gaap	Cash Cash	48000	usd
CY2021Q3	us-gaap	Short Term Investments ShortTermInvestments	66600	usd
CY2021Q3	us-gaap	Cash Cash	60000	usd
CY2021Q1	us-gaap	Public Utilities Approved Rate Increase Decrease Percentage PublicUtilitiesApprovedRateIncreaseDecreasePercentage	0.17	pure
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	47520	usd
CY2022Q2	us-gaap	Cash Cash	44000	usd
CY2022Q2	us-gaap	Public Utilities Approved Rate Increase Decrease Percentage PublicUtilitiesApprovedRateIncreaseDecreasePercentage	0.17	pure
CY2022Q4	onfolio	Company Owed CompanyOwed	68959	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1314	usd
CY2022	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	0	usd
CY2021	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-1314	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-889215	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	399307	usd
CY2022	onfolio	Permanent Differences PermanentDifferences	235561	usd
CY2021	onfolio	Permanent Differences PermanentDifferences	161286	usd
CY2022	onfolio	Operating Loss Carryforwards1 OperatingLossCarryforwards1	653654	usd
CY2021	onfolio	Operating Loss Carryforwards1 OperatingLossCarryforwards1	238021	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	usd
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	onfolio	Provision For Income Taxes Current ProvisionForIncomeTaxesCurrent	0	usd
CY2021	onfolio	Provision For Income Taxes Current ProvisionForIncomeTaxesCurrent	0	usd
CY2022	onfolio	Temporary Equity Other Changes1 TemporaryEquityOtherChanges1	0	usd
CY2021	onfolio	Temporary Equity Other Changes1 TemporaryEquityOtherChanges1	-1314	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1314	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	918400	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	238021	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	918400	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	238021	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd

Files In Submission

Name	View Source	Status
0001654954-23-004611-index-headers.html	Edgar Link	pending
0001654954-23-004611-index.html	Edgar Link	pending
0001654954-23-004611.txt	Edgar Link	pending
0001654954-23-004611-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
onfolio-20221231.xsd	Edgar Link	pending
onfolio_10k.htm	Edgar Link	pending
onfolio_10kimg6.jpg	Edgar Link	pending
onfolio_ex211.htm	Edgar Link	pending
onfolio_ex221.htm	Edgar Link	pending
onfolio_ex311.htm	Edgar Link	pending
onfolio_ex312.htm	Edgar Link	pending
onfolio_ex321.htm	Edgar Link	pending
onfolio_ex322.htm	Edgar Link	pending
onfolio_ex46.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
onfolio-20221231_cal.xml	Edgar Link	unprocessable
onfolio-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
onfolio-20221231_def.xml	Edgar Link	unprocessable
onfolio-20221231_lab.xml	Edgar Link	unprocessable
onfolio_10k_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONFO
Onfolio Holdings, Inc Stock $onfo

2023 Q1 Form 10-K Financial Statement

#000165495423004611 Filed on April 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO Onfolio Holdings, Inc Stock $onfo

2023 Q1 Form 10-K Financial Statement

#000165495423004611 Filed on April 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO
Onfolio Holdings, Inc Stock $onfo